Navigation Links
Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
Date:7/29/2008

Three Months Ended Twelve Months Ended

September 30, 2008 December 31, 2008

Projected GAAP basic income

per common share $0.99 - $1.09 $3.71 - $3.81

Amortization of current

intangibles $0.37 - $0.37 $1.53 - $1.53

Accelerated depreciation

adjustment $0.02 - $0.02 $0.10 - $0.10

Research and development

adjustments $- - $- $0.11 - $0.11

Selling, general and

administrative adjustments $- - $- $0.04 - $0.04

In-process research and

development adjustments $- - $- $0.15 - $0.15

Restructuring adjustments $0.02 - $0.02 $0.13 - $0.13

Interest expense adjustment $- - $- $0.11 - $0.11

Tax effect of pre-tax

adjustments at the

applicable tax rates $(0.15) - $(0.15) $(0.78) - $(0.78)

Basic adjusted income

per common share

guidance $1.25 $1.35 $5.10 $5.20

The company's guidance is being issued based on certain assumptions

including:

-- Adjusted effective tax rate of approximately 35.5 to 36.5 percent; and

-- Weighted average number of common shares outstanding of 68.0 and 67.9

million shares for the three months ended September 30, 2008 and for

the twelve months ended December 31, 2008, respectively.


'/>"/>
SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/15/2014)... Biotechnology Company, Limited ("TaiGen") today announced that they have ... pharmaceutical company, to develop and commercialize nemonoxacin (Taigexyn ® ... Turkey and other members of ... for the treatment of bacterial infections including those caused ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Histogen, ... the products of cells grown under simulated embryonic conditions, ... license agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... , This agreement is an amendment to ...
(Date:1/14/2014)... New York, NY (PRWEB) January 14, 2014 ... coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua is an ... products to serve the wound care market. , Free ... Alliqua was restructured with a seasoned management team and ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Nottingham have made a major breakthrough that could help shape ... that 3-D molecular structures can be built on a surface. ... the development of new nano devices such as cutting-edge optical ... paper published in the prestigious journal Nature Chemistry , ...
... -- The review process being used by the Food and ... salmon fails to weigh the full effects of the fish,s ... in this week,s Science . The salmon, whose ... become the first genetically modified animal approved for human consumption ...
... Crescent Healthcare today announced a planned expansion of ... lease to open an infusion pharmacy in Totowa, New ... to current patients in Massachusetts, Maryland, New York, New ... Island. In addition to supporting current ...
Cached Biology Technology:World-first to provide building blocks for new nano devices 2FDA review on transgenic salmon too narrow 2FDA review on transgenic salmon too narrow 3Crescent Healthcare Expands East Coast Presence 2
(Date:4/17/2014)... produce hydrogen sulfide in order to properly multiply and ... the Center for Craniofacial Molecular Biology at the Herman ... Shi, principal investigator on the project, said the presence ... flow of calcium ions. The essential ions activate a ... the creation of new bone tissue, and keeps the ...
(Date:4/17/2014)... devastate honeybees in Europe, Asia and the United States ... to be impacting native honeybee populations at this time, ... pests include including Nosema microsporidia and ... be resilient to these invasive pests, which suggests to ... Europe, Asia and the United States currently are not ...
(Date:4/17/2014)... meeting painted a stark warning on the possible effects ... greenhouse effect 32 times that of carbon dioxide. Now ... substances act as fully regenerable electron acceptors which helps ... wetlands instead of being released to the atmosphere. However, ... it may enter into a vicious cycle to release ...
Breaking Biology News(10 mins):East African honeybees are safe from invasive pests… for now 2East African honeybees are safe from invasive pests… for now 3Methane climate change risk suggested by proof of redox cycling of humic substances 2
... email messages, from bananas to home-grown tomatoes: everything we buy, produce ... called a "footprint". And if you want to be a good ... can use to understand just how big your footprint is ... But what if you are a government decision maker and ...
... generate a lot of smoke visible on NASA satellite imagery. ... smoke to the north-northeast and into Wyoming and southwestern Nebraska ... located approximately 15 miles west of Fort Collins, Colo., and ... been lost, according to the U.S. Forest Service. More than ...
... an issue faced by teenagers and young women, but a new ... women aged 50 and over, 3.5% report binge eating, nearly 8% ... The study published in the International Journal of Eating Disorders ... shape negatively impacted on their life. The researchers, led by ...
Cached Biology News:A virtual crystal ball 2A virtual crystal ball 3A virtual crystal ball 4Eating disorder behaviors and weight concerns are common in women over 50 2
Request Info...
DITHIOTHREITOL, 150UMOL, 1 EA. Dithiothreitol (DTT), 0.1 M Solution:, *0.1 M solution of DTT in high purity dH2O., *0.2 m filtered., *Storage: -20C. Category: SEQUENASE....
... Cary 50 Microplate Reader accessory ... per analysis by extending the ... award-winning Cary 50 instruments. Use ... 384 samples in microlitre volumes, ...
... use with T4 Polynucleotide Kinase for ... ends) of nucleic acids. In the ... the 5' phosphate group from DNA ... Gamma-phosphate of ATP to the free ...
Biology Products: